Synopsis:
We aimed to study the therapeutic effect and safety of high-intensity-focused ultrasound (HIFUT) combined Gemcitabine on unresectable pancreatic carcinoma in clinic. Our results showed that HIFUT combined gemcitabine is better than gemcitabine only. The former treatment (HIFUT combined gemcitabine) may become a better effective treatment strategy for treating unresectable pancreatic carcinoma.